MedMen Stock: Operational Performance Shows Upside Ahead

MedMen Stock

In late 2018, MedMen stock took a massive tumble from $7 to just above $2 on the OTC. Then 2019 kicked in, bringing with it several attempts of recovery from MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF).

Unfortunately, on every occasion, the shares failed to either breach or hold above the $3.50 mark. But now, MedMen stock is on a climb once again; so, can it hold above the strong resistance at $3.50 this time?

MedMen Stock

At the time of writing, MedMen stock is selling for $3.01 USD on the OTC. Looking at the company’s chart since the beginning of 2019, a trend is clear to see:

Capitalize off Cannabis
Sign up now to start receiving our investing insights for FREE!

 

Source: Bloomberg Stock Quote – MMNFF on the OTC

But despite the stagnating stock, the LA-based cannabis firm has been busy in 2019. Operations are in full swing. With assets across the US in major market states such as New York, Nevada, California, and Florida, MedMen Enterprises holds value “which goes beyond the price of the stock.”

>> TLRY Stock: Insider Selling is New Headache for Tilray

MedMen Stock vs 2019 Operations So Far

  • The company completed two acquisitions: a dispensary in Illinois, and a vertically-integrated operator in Arizona.
  • Then it announced the completion of a real estate sale to cannabis REIT. Further, in mid-March, it completed the sale of two more properties to cannabis REIT.
  • Also in March, the company received a $250 million large investment from Gotham Green Partners.
  • Lastly, it expanded its retail reach through Northern California through the acquisition of licensed cannabis retailer, Sugarleaf Trading Co.

MedMen Stock Progress

According to Microcapdaily, MedMen CEO Adam Bierman has expansion plans for California as he sees “the Californian market as the most important one for the cannabis industry in the world.”

With its eyes set on the biggest cannabis market on the planet, and once pending acquisitions close, MedMen Enterprises will have a total of 32 stores, and 17 licensed factories, across 12 different US states. With such reach, there is a lot of potential ahead, and MedMen stock can only catch up.

What do you think? Are you a fan of MedMen stock?

>> Read More MedMen News

Featured Image: Canva